Cleared Special

Xpert? SA Nasal Complete

K243070 · Cepheid · Microbiology
Oct 2024
Decision
28d
Days
Class 2
Risk

About This 510(k) Submission

K243070 is an FDA 510(k) clearance for the Xpert? SA Nasal Complete, a System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen (Class II — Special Controls, product code NQX), submitted by Cepheid (Sunnyvale, US). The FDA issued a Cleared decision on October 25, 2024, 28 days after receiving the submission on September 27, 2024. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K243070 FDA.gov
FDA Decision Cleared SESE
Date Received September 27, 2024
Decision Date October 25, 2024
Days to Decision 28 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code NQX — System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.1640
Definition A Nucleic Acid Amplification Assay System (including Probes, Other Reagents, And Instrumentation) Is An Aid In The Identification Of Mrsa Colonization Status For The Prevention And Control Of Mrsa Infections In Healthcare Settings.

Similar Devices — NQX System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

All 23
Xpert MRSA/SA SSTI
K243625 · Cepheid · Dec 2024
ARIES MRSA Assay
K191742 · Luminex Corporation · Sep 2019
Xpert MRSA/SA Blood Culture, GeneXpert Dx System, GeneXpert Infinity-48s System, GeneXpert Infinity-80 System
K190771 · Cepheid · Apr 2019
Xpert MRSA NxG
K162444 · Cepheid · Nov 2016
cobas MRSA/SA Test
K142721 · Roche Molecular Systems, Inc. · Dec 2014
BD MAX MRSA XT, BD MAX INSTRUMENT
K133605 · Geneohm Sciences Canada, Inc. · Dec 2013